Continued investment and technical support for the expansion, operation and maintenance of oxygen infrastructure are still urgently needed to improve overall health outcomes and achieve universal health coverage, according to Unitaid.
The Medicines Patent Pool (MPP) and Merck on Wednesday announced the signing of a voluntary licensing agreement to facilitate affordable global access for Molnupiravir.It is an investigational oral Covid-19 antiviral medicine for the treatment .
Unitaid’s Executive Director Philippe Duneton warned about the critical need for investment in oxygen to treat COVID-19 patients in low- and middle-income countries, which have quadrupled in recent months. UNITAID<br />